GlassScriptPhysician profile
Jessica Teeter
NPI 1003524216
$1,378.91
in general payments reported to CMS, 2019-2025
23 companies · $494 in 2025
The $494 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $575 · 2024: $309 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,378.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $306.97 | 2023-2024 | Jardiance, Lyumjev, Baqsimi |
| Novo Nordisk INC | $133.61 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.08 | 2023-2025 | Jardiance |
| Bridgebio Pharma, INC. | $95.92 | 2025 | Attruby |
| Abiomed | $67.55 | 2025 | |
| Sanofi-Aventis U.S. LLC | $62.55 | 2023-2024 | |
| Amgen INC. | $61.86 | 2023-2025 | Prolia, Evenity, Repatha |
| Abbvie INC. | $59.50 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $56.99 | 2024-2025 | |
| Cequr Corporation | $53.36 | 2023-2024 | Cequr Simplicity |
| Mannkind Corporation | $48.16 | 2023 | Afrezza |
| Insulet Corporation | $40.84 | 2023-2024 | Omnipod |
| Dexcom, INC. | $35.35 | 2024 | Dexcom G6 Transmitter |
| Scpharmaceuticals INC. | $33.39 | 2025 | |
| Xeris Pharmaceuticals, INC. | $32.04 | 2023 | Recorlev |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | $31.57 | 2023 | NP Thyroid 60 |
| Astrazeneca Pharmaceuticals LP | $29.43 | 2025 | Farxiga |
| Chiesi USA, INC. | $24.82 | 2025 | Kengreal |
| Kyowa Kirin, INC. | $22.56 | 2023 | Crysvita |
| Kiniksa Pharmaceuticals International, Plc | $21.30 | 2024 | Arcalyst |
| Tandem Diabetes Care, INC. | $18.66 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Actelion Pharmaceuticals US, INC. | $15.08 | 2025 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $14.32 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Teeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.